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Background: Understanding of an athlete’s lifespan is limited with a much more sophisticated knowledge of their
competitive careers and little knowledge of post-career outcomes. In this review, we consider the relationship
between participation at elite levels of sport and mortality risk relative to other athletes and age- and sex-matched
controls from the general population. Our objective was to identify, collate, and disseminate a comprehensive list of
risk factors associated with longevity and trends and causes of mortality among elite athletes.
Methods: English language articles were searched using the Web of Science database. Keywords athletes, death,
elite, “high performance” life expect*, longevity, mortality, players, professional, and sport were used to locate research
articles. Seventeen additional articles were retrieved from reference lists found in these papers and a general web
search. The inclusion criteria were the following: (1) publication year 1980 or later; (2) the study examined elite-level
athletes; and (3) outcome data measured mortality/longevity trends and/or causes.
Results: Fifty-four peer-reviewed publications and three articles from online sources met the criteria for inclusion.
Baseball, football, soccer, basketball, and cycling had the most reported data on elite athletes’ lifespan longevities.
A variety of mechanisms have attempted to explain mortality risk (e.g., handedness, playing position, achievement,
etc.). Considerable support was found for superior longevity outcomes for elite athletes, particularly those in
endurance and mixed sports.
Conclusions: Future research into the mechanisms that may affect mortality risk is important for a better
understanding of life expectancies in both eminent and non-eminent populations. Participation in elite sport is
generally favorable to lifespan longevity.
Key Points:
 A majority of studies included in this review reported superior lifespan longevity outcomes for elite athletes
compared to age- and sex-matched controls from the general population and other athletes.
 Several mechanisms within and between sports may have powerful effects on the overall lifespan longevities
of players (e.g., type of sport, playing position, race, and energy system).
 Future research on mortality in elite athletes would benefit from more comprehensive statistical measures and
reliable databases to determine potential mechanisms that may influence mortality trends and causes in both
athlete and non-athlete samples.
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Rationale
Researchers have given considerable attention to the athlete
development process (e.g., positive youth development
through sport) (see [1]). Interestingly, insight into post-
career outcomes is significantly limited. For instance, our
knowledge of how participation in elite sport affects life-
span longevity is particularly incomplete. This lack of infor-
mation about later phases of athletes’ lifespans may be
attributable to several factors, such as the greater access to
athletes during their competitive careers as well as the
preponderance of participation- and performance-based
theories focusing on elements related to understanding the
antecedents of sporting success (e.g., [2]). Attaining a
complete understanding of an athlete’s lifespan requires
knowledge of the inherent complexity of relationships that
link hereditary and environmental characteristics to devel-
opmental outcomes. In this study, we focus on mortality of
previously elite athletes.
An important challenge to mortality research in sport is
the lack of data on the health behaviors of athletes post re-
tirement. Much of our current understanding of trends and
causes in elite athlete mortality derives from what appear to
be “one-off” studies by small teams of researchers. Past
work examining this issue in depth appears to be limited,
although the Finnish studies that examined lifespan longev-
ities of former elite endurance, team, and power athletes
who represented Finland between the years 1920 and 1965
are exceptions (e.g., [3–6]). In addition, views on elite ath-
lete mortality are largely shaped by popular media sources,
which may downplay tenets of the lifespan and create false
perceptions of early mortality in athletes (e.g., MLB’s Tony
Gwynn at 54 years [cancer], the NFL’s Junior Seau at
43 years [suicide], boxing’s Tommy Morrison at 44 years
[AIDS], sailing’s Andrew Simpson at 36 years [drowning]
and skiing’s Sarah Burke at 29 years [training fall]).
A recent meta-analysis completed by Garatachea et al.
[7] indicated that elite athletes live longer than the gen-
eral population, with an all-cause pooled standard mor-
tality ratio (SMR) of 0.67 (95 % confidence interval [CI]
0.55–0.81; P < 0.001). Further, they found a lower risk of
cardiovascular disease (CVD) and cancer in those who
participated in high-performance sport, which empha-
sized the health benefits of exercise [7]. While their
study makes an important contribution to our know-
ledge of longevity outcomes in elite sport, the restrictive
sampling frame necessary for a meta-analysis excluded
numerous studies that could inform our broader under-
standing of elite athlete health. For example, Garatachea
et al. [7] included 10 studies of elite athlete longevity in
their meta-analyses, but their inclusion criteria excluded
studies that did not use SMR as a statistical measure of
mortality (38 studies were excluded for this reason). As
a result, studies with important information regardinglongevity in elite athletes were excluded, such as greater
longevity in Norwegian professional divers (hazard ratio
[HR] = 0.79, 95 % CI 0.63–0.997) [8], and important
mechanisms that may influence longevity, such as sex,
as indicated by Olympic medal-winning females having
greater longevity relative to Olympic medal-winning
male athletes (HR = 0.61, 95 % CI 0.51–0.72) [9], and
race, as indicated by African-American professional bas-
ketball players having a 77 % greater risk of death com-
pared with white players (HR = 1.77, 95 % CI 1.35–2.32)
[10]. Further, several studies which reported SMRs were
not included in the meta-analysis (e.g., [11–15]). As
such, there is an opportunity to grow our current limited
understanding of longevity outcomes of elite athletes by
examining a wider range of studies and sports through a
systematic review.
Similarly, Teramoto and Bungum [16] completed a nar-
rative review of mortality and longevity of elite athletes;
however, a relatively small sample of 14 epidemiological
studies was included. Their primary method of literature
retrieval was through the PubMed (1950-) and Scopus
(1960-) databases, using keywords mortality, longevity, life
expectancy, death, and (elite/professional) athletes and
players. While this literature search strategy was appropri-
ate, a large number of studies on elite athlete mortality
and longevity were published during or after their pub-
lication year of 2010 (e.g., [3, 8–10, 12, 13, 15, 17–31]).
As a result, mechanisms such as race have since been
validated as more consistent indicators of early mortal-
ity (e.g., [10, 19]). Currently, it may be premature to
make conclusions about the long-term value of being a
professional athlete considering the new evidence that
has emerged from literature.
Although it appears that there are many unanswered
questions concerning athletes’ lifespan longevities, Teramoto
and Bungum [16] presented enough empirical evidence to
determine some cross-sport and energy system trends.
Teramoto and Bungum [16] found a trend towards endur-
ance (e.g., long-distance runners) and mixed-sport (e.g.,
soccer) athletes having more favorable survival outcomes
relative to power sport (e.g., weightlifters) athletes and the
general population. Similarly, a meta-analysis performed
by Löllgen et al. [32] examined 38 studies that measured
physical activity and all-cause mortality in samples of
physically active individuals (non-elite athletes) and re-
ported an overall significant relationship between physical
activity participation and lower all-cause mortality. Light
and moderate intensity levels of activity were generally as-
sociated with a reduction in mortality, whereas training at
high intensities was not required for the main prevention
against all-cause mortality [32]. While Löllgen and col-
leagues [32] provided evidence of physical activity posi-
tively influencing lifespan longevity independent of age
and sex, the relationship between participation in elite
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benefits of physical activity at the highest levels of compe-
tition in unique athletic cohorts.
Teramoto and Bungum’s [16] review suggested that
the type and dose of elite sport participation may ultim-
ately determine mortality risk. In addition, Teramoto
and Bungum [16] highlighted the importance of con-
sidering elite athletes as a heterogeneous group with re-
spect to mortality trends; differences between and within
sports exist. In particular, the differences in health-
related behaviors between and within sports may also
create modifiable factors that are associated with longev-
ity and mortality. As a result, overall mortality risk is ex-
plained by several modifiable factors, such as obesity
and physical inactivity, and non-modifiable (unchange-
able) factors, such as age and race, that are unique to
athletes. For instance, Baron et al. [19] found an overall
decrease in mortality in National Football Players (NFL)
who were active between 1959 and 1988; however, de-
fensive linemen had increased mortality from CVD and
cardiomyopathy. Moreover, those with a playing time
body mass index (BMI) of >30 kg/m2 had a significantly
higher risk of CVD, which was also influenced by race/
ethnicity [19]. Although the effects of playing position
on lifespan longevity may be more pronounced in con-
tact sports such as football, we cannot overlook the
differences and nuances in health-related behaviors be-
tween and within sports that may influence lifespan
longevities.
Objectives
A subject such as death rates in professional athletes
may be more susceptible to sensationalism when trends
begin to emerge; therefore, it is essential that the data
being disseminated are transparent and accurate. In this
review, we consider the relationship between participa-
tion at elite levels of sport and mortality risk relative to
other athletes and age- and sex-matched controls from
the general population. Our objective was to extend
the narrative review of Teramoto and Bungum [16]
with a more comprehensive and up-to-date list of
studies on mortality and longevity in previously elite
athletes. More specifically, our aim was to advance
knowledge in this area by collating athlete mortality/
longevity literature that may help refine future analytic
methods, form evidence-based models of athlete longev-
ity, and determine whether elite-level participation in
high-performance sport produces a lifespan longevity ad-
vantage. Similar to Teramoto and Bungum’s [16] research
questions, we asked the following: (1) do elite athletes
have superior longevity outcomes relative to the general
population, and (2) which mechanisms and risk factors
are associated with longevity and are potential precursors
to early mortality?Methods
Literature Search
A systematic review of literature was performed using the
Web of Science database (1 January 1980–30 September
2014; see Tables 1 and 2). Web of Science was chosen
as our primary citation index as it contained over 90
million records through its 7 online databases, which
would have made searches into smaller citation indexes
largely redundant (e.g., EMBASE contains over 28
million records). Further, given this review’s objective,
Web of Science’s databases appeared to be the most
relevant to our study (e.g., Science Citation Index
Expanded). Keywords, including athletes, death, elite,
“high performance” life expect*, longevity, mortality,
players, professional, and sport, were used to locate re-
search articles. While a full electronic search strategy
for at least one database is recommended [33], we fur-
ther located research articles by searching the references
of records that were identified through our database
search, in addition to performing a general web search
through the Google Scholar search engine.
Inclusion Criteria
The inclusion criteria were the following: (1) publication
year 1980 or later; (2) the study examined elite-level ath-
letes; and (3) outcome data measured mortality/longevity
trends and/or causes. We excluded studies with no full-
text availability (abstracts, conference proceedings, com-
mentaries, and editorials), no English-text availability
(a small proportion of international articles were unavail-
able for translation to English), other literature reviews
with different inclusion criteria (e.g., non-elite samples),
duplicates, case reports, studies on morbidity (i.e., CVD
risk factors, etc.), psychosocial measures, collegiate ath-
letes, and studies on the effectiveness of pre-screening
strategies and prevention. For consistency, we use “elite”
synonymously with any form of high-performance partici-
pation in sport (i.e., national, professional, and inter-
national competition such as the Olympics).
Data Extraction
We identified 1001 records through database searching
using the aforementioned keywords. After review of title
and abstract, we excluded 961 of those records (identical
papers, n = 31; inclusion criteria not fulfilled, n = 930;
most commonly due to studies not examining elite ath-
letes and/or mortality/longevity trends), which left 40
eligible full-text articles from the Web of Science data-
base search. Seventeen additional articles were retrieved
from reference lists found in these papers and a general
web search. In total, 57 studies filled the criteria for in-
clusion (Tables 1 and 2): 54 peer-reviewed publications
(see Table 1), in addition to three articles from online
sources included to investigate findings of mortality risk
Table 1 Peer-reviewed elite athlete mortality literature (>1980; n = 54)
Sport/Country Authors N Key finding LE vs. GP
MLBa Abel and Kruger [35] (2004) 6038 Significant differences in longevity related to handedness
(F[2,6035] = 0.13) (death < 2001)
–
MLBa Abel and Kruger [36] (2005) 2604 LE: ~4–5 years longer (f = 188.0, df = 1, 2,555, P < 0.001);
(1900–1950 debut)
↑
MLBa Abel and Kruger [37] (2005) 3573 Median post-induction survival for HOFs was 5 years shorter
than for non-inducted players, 18 years (CI 15.0–21.0) vs.
23 years (CI 22.1–23.9) for matched controls (OR = 1.37,
CI 1.08–1.73); (death≤ 2002)
–
MLBa Abel and Kruger [38] (2006) 4492 LE: 4.8 years longer (SD = ±15.0); career length increased
longevity (F = 3.4 df = 3,4379; P < 0.02); (1900–1939 debut)
↑
MLBa Abel and Kruger [39] (2007) 3760 Earlier career debut predicted earlier death (F[8,2898] = 7.78,
P < 0.001); (death < 2006; 1900–1935 debut)
–
MLBa Abel and Kruger [40] (2007) 3835 Players (n = 11) with positive initials (e.g., A.C.E.; 80.4 ± SE = 3.0)
lived significantly longer (F[2904] = 3.7, P < 0.03, two-tailed) by
13 years than players (n = 30) with negative initials (e.g., D.E.D.;
67.0 ± SE = 3.1) or players (n = 864) with neutral initials
(67.1 ± SE = 0.5); players with positive initials lived significantly
longer than their matched controls and those with negative
initials (P < 0.05); (died before 1950)
–
MLBa Boren and Erickson [41] (1998) 28 The most common toxin that lead to death by poisoning was
carbon monoxide; low overall risk (death 1889–1995)
–
MLBa Fudin et al. [42] (1993) 1686 In response to Halpern and Coren’s [43] study: Left-handers
(n = 235) had a M longevity of 64.46 years (SD = 15.34) right-
handers (n = 1451), a difference of 38.57 days (t[1684] = 0.09,
P > 0.05 for compared to 64.56 years (SD = 15.02) for years
lived; Halpern and Coren [43] reported a difference of
244.72 days); (considered longevity data through 1978)
–
MLBa Halpern and Coren [43] (1988) 1708 M age at death for right-handers was 64.64 years (n = 1472;
SD = 15.5) and 63.97 years for left-handers (n = 236; SD = 15.4),
a significant difference (Z = 6.63, P < 0.001)
–
MLBa Hicks et al. [44] (1994) 5441 In response to Fudin et al.’s [42] study: Reliable data were
confirmed for 3501 right-handers (64.3 %), 1199 mixed-handers
(22.0 %) and 741 left-handers (13.6 %); the differences in M
days of life were not significant in each group (F[2,5338] = .59,
P = 0.55) and between just right- and left-handers
(t[4240] = −1.08, P = 0.28; M longevity less for right-handers)
–
MLBa Kalist and Peng [45] (2007) 2641 Greater longevity overall (SMR = 0.31); positive relationship
between education and longevity (HR = 0.74, CI 0.56–0.977);
black players had a HR 2.47 times greater than white players
(1963–1996 debut)
↑
MLBa Reynolds and Day [15] (2012) 14,360 Greater longevity rates throughout the last century (1900–1999
debut); (SMR = 0.87, CI 0.85–0.89; 1930–1999)
↑
MLBa Saint Onge et al. [46] (2008) 6772 LE: ~5 years longer, compared to 20-year-old U.S. males; at
20 years, players from the Modern Era can expect to live
65.5 vs. 52.4 years and 58.3 years from the Early and Golden
Eras, respectively (1902–2004 debut)
↑
MLBa Smith [29] (2011) – In response to Abel and Kruger’s [40] study: No relationship
between name initials and longevity (P > 0.05)
–
MLBa Smith [30] (2011) 102 In response to Abel and Kruger’s [37] study: Corrected data
shows that there is no statistically significant difference in the
LE of HOF players (Z = 0.06, two-sided P = 0.952)
–
MLBa Waterbor et al. [47] (1988) 985 Greater longevity overall (SMR = 0.94); longevity was correlated
with position and in-game achievement (1911–1925 debut)
–
NBAa Fafian Jr. [48] (1997) 2810 Greater longevity overall, particularly in guards
(active 1946–1994)
↑
NBAa Lawler and Lawler [25] (2011) 3647 Handedness was not significantly related to LE (HR = 0.92,
CI 0.54–1.60; P = 0.76); (active 1946–2009)
–
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Table 1 Peer-reviewed elite athlete mortality literature (>1980; n = 54) (Continued)
NBAa Lawler et al. [10] (2012) 3366 White players lived longer (~1.5 years) than black players
(HR = 1.77, CI 1.35–2.32); LE: ~4 year longer overall
(active 1946–2005)
↑
NFLa Abel and Kruger [49] (2006) 1512 LE: 6.1 years longer (SD = ±11.9); career length (F = 4.7,
df = 2,1504; P < 0.01) and BMI (R² = 0.01, P < 0.01) increased
longevity (debut < 1940)
↑
NFLa Baron et al. [19] (2012) 3439 Greater longevity overall (SMR = 0.53, CI 0.48–0.59); BMI, race,
and position were associated with longevity (active 1959–1988)
↑
NFLa Lehman et al. [12] (2012) 3439 Greater longevity overall (SMR = 0.53, CI 0.48–0.59); increased
overall risk of neurodegenerative MR (SMR = 2.83–3.26,
CI 1.36–5.21); elevated ALS (SMR = 4.31, CI 1.73–8.87) and AD
(SMR = 3.86, CI 1.55–7.95) subcategories (active 1959–1988)
↑
NFLa Selden et al. [50] (2009)b – Review of recent data suggests ↑ CVD risk factors in players,
particularly linemen
–
Boxing Baird et al. [18] (2010) 339 Decline in premature MR after 1983 (rounds reduced from
15 to 12); (death 1950–2007)
–
Cricketc Aggleton et al. [51] (1993) 3165 There was a significant lifespan longevity difference
(t[3163] = 2.77, P = 0.006, two-tailed) between right-handers
(n = 2580; 65.62 years) and left-handers (n = 585; 63.52 years);
left-handers were more likely to die prematurely in accidents
or in warfare (players in the British Isles from 1864–1983)
–
Cricketc Aggleton et al. [52] (1994) 5960 No significant relation between mortality and handedness
(P = 0.3); left-handers were more likely to die from unnatural
causes (P = 0.03, log hazard 0.37, CI 0.04–0.70), particularly
warfare (P = 0.009, log hazard 0.53, CI 0.13–0.92); (born between
1840–1960; players in the British Isles from 1864–1992)
–
Cyclistsd Marijon et al. [27] (2013) 786 Greater longevity overall in Tour de France participants
(SMR = 0.59, CI 0.51–0.68, P < 0.0001); reduction in neoplasms
(SMR = 0.56, CI 0.42–0.72, P < 0.0001) and CVD (SMR = 0.67,
CI 0.50–0.88, P = 0.004); (1947–2012 participants)
↑
Cyclistsd Morcet et al. [13] (2012) 514 Greater longevity overall (SMR = 0.50, CI 0.34–0.71); although
higher MR in younger cyclists (active 1960–1990)
↑
Cyclistsd,e,f Sanchis-Gomar et al. [28] (2011) 834 LE: ~8 years longer for Tour de France participants (P < 0.05);
(active 1930–1964)
↑
Divingg Irgens et al. [8] (2013) 3130 Greater longevity overall (HR = 0.79, CI 0.63–0.997), although
increased violent deaths (born 1950–1999)
↑
Golfa Coate and Schwenkenberg [21] (2012) 313 LE: 5.4 years longer (won prize money 1980–2009) ↑
Golfh Farahmand et al. [11] (2009) 300,818 Greater longevity overall (SMR = 0.60, CI 0.57–0.64); greatest
longevity in most skilled players (SMR = 0.53, CI 0.41–0.67);
(born >1920, registered < 2001)
↑
PLi Pärssinen et al. [53] (2000) 62 Increased premature MR (SMR = 4.6, CI 2.04–10.45; P = 0.0002),
suspected from prior anabolic steroid use (placed first–fifth in
Finnish championships, 1977–1982)
↓
Rugbyj Beaglehole and Stewart [54] (1983) 822 LE of All Blacks is the same as GP, although LE (73.0 years) for
non-Māori All Blacks was ~10 years longer (CI 71.8–74.5)
relative to the Māori All Blacks (1884–1981)
=
Skiingg Grimsmo et al. [22] (2011) 122 Total MR was 9 % lower after a 30-year follow-up (P = 0.04);
(study participants, 1976–1981)
↑
Soccere Belli and Vanacore [55] (2005) 350 Similar observed and expected MR, although a ten-fold
increase of ALS MR (SPMR = 1158, CI 672–1998) was present
(active 1960–1996)
=
Soccerk Koning and Amelink [23] (2012) 371 Greater longevity overall (P = 0.003); (active 1970–1973) ↑
Soccerl Kuss et al. [24] (2011) 812 Cumulative observed survival was smaller than cumulative
expected survival; therefore, male and female players had
reduced longevity (RSR≤ 1); (active 1908–2006)
↓
Soccere Taioli [56] (2007) 5389 Greater longevity overall (SMR = 0.68, CI 0.52–0.86), although
increased risk for car accident (SMR = 2.23, CI 1.46–3.27) and
ALS (SMR = 18.18, CI 5.00–46.55) death (active 1975–2003)
↑
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SWm Kanda et al. [57] (2009) 73 Deceased wrestlers had higher BMIs (OR = 1.08, CI 1.01–1.15)
and winning percentages (OR = 1.29, CI 0.86–1.93);
(active 1926–1989)
–
T and Fc Menotti et al. [58] (1990) 983 Greater longevity in males (SMR = 0.73; n = 700) and females
(SMR = 0.48; n = 283); significant when analyzed together
(P = 0.0296); (active > 1940)
↑
Mixeda Abel and Kruger [17] (2010) 10,216 Decrease in longevity associated with names beginning with
A–D; linear decrease for baseball and hockey players, but
non-linear in football and basketball players; for each sport,
A names lived longer than E–Z names, and D names had
decreased longevities compared to E–Z names F(4,10,193) = 4.16,
P = 0.002); football players lived the longest (72.3 ± 12.7) and
baseball players lived the least years (70.8 ± 14.7); significant letter
differences occurred between A and E–Z (HR = 0.80, CI 0.71–0.91,
P < 0.001) and D and E–Z (HR = 1.16, CI 1.04–1.30, P < 0.01); (born
1875–1930)
–
Mixed Bianco et al. [59] (2007) 715 Baseball (LE: 76; n = 154), basketball (LE: 78; n = 58), boxing
(LE: 73; n = 81),football (LE: 77; n = 81), ice hockey (LE: 74.5;
n = 130), swimming (LE: 74; n = 37), tennis (LE: 79; n = 83), track
and field (LE: 75; n = 59), and wrestling (LE: 77; n = 32) HOFs
had greater overall longevity (P < 0.05); (M = 76 years);
(born 1860–1930)
↑
Mixed Clarke et al. [20] (2012) 15,174 11,619 (76.6 %) male and 3555 (23.4 %) female Olympic Game
medalists’ (1896–2010) LE was 2.8 years longer (RCS = 1.08,
CI 1.07–1.10); endurance (RCS = 1.13, CI 1.09–1.17) and mixed
(RCS = 1.11, CI 1.09–1.13) sport athletes had a more favorable
survival advantage relative to power sport athletes (RCS = 1.05,
CI 1.01–1.08)
↑
Mixeda Coate and Sun [9] (2013) 2690 Females (n = 1348; HR = 0.61, CI 0.51–0.72) had a ~6 year LE
advantage over males (n = 1342), even though they competed
in the same Olympic events (1900–2008) and tennis
championships (HR = 0.65, CI 0.47–0.91; >1880); Olympic
medalists’ LE: 2–3 years longer if born <1920, but smaller
advantage overall; tennis players’ LE: 5–6 years longer if born
<1920, and 2–3 years overall; M LE was 82 years for females
and 76 years for males
↑
Mixedn Gajewski and Poznańska [60] (2008) 2113 Greater longevity overall in male (n = 1689; SMR = 0.50,
CI 0.44–0.56) and female (n = 424; SMR = 0.73, CI 0.48–1.05)
Olympians (1924–2000)
↑
Mixedi Kettunen et al. [3] (2014) 2363 LE: ~5–6 years longer overall; endurance (79.1 years;
CI 76.6–80.6), team (78.8 years; CI 78.1–79.8) and power
(75.6 years; CI 74.0–76.5) sport athletes who represented
Finland in international competitions (active 1920–1965)
had higher LE than controls (72.9 years, CI 71.8–74.3), even
after adjusting for socio economic status, birth cohort, and
disease-specific mortality (HR≤ 1); boxers had increased risk
of dementia mortality (HR = 4.20, CI 2.30–7.81)
↑
Mixedi Kujala et al. [4] (2001) 2009 Greater longevity overall (SMR = 0.74, CI 0.69–0.79); all-cause
mortality was lower for endurance (SMR = 0.57, CI 0.47–0.68),
mixed (SMR = 0.68, CI 0.61–0.76), and power (SMR = 0.90,
CI 0.81–1.00) sport athletes who represented Finland in
international competitions (active 1920–1965); increased risk of
hypertension in power sport athletes (SMR = 2.63, CI 1.06–5.42);
(SMRs calculated 1971–1995)
↑
Mixedh Lindqvist et al. [26] (2013) 1199 MR was not increased overall in former power sport athletes,
except a slight increase at 45 years (CI 2.1–4.2); between 20
and 50 years, estimated HR = 1.44–1.46; 2.1–3.9 times increased
MR from suicide between 30 and 50 years (overall, HR = 1.74,
CI 1.08–2.66; P = 0.025); however, there was a lower malignancy
MR (HR = 0.71, CI 0.50–0.98; P = 0.036); (active 1960–1979)
–
Mixedn Poznańska and Gajewski [14] (2001) – Greater overall longevity (SMR = 0.42, CI 0.35–0.49), particularly
between 1992 and 1998 (Olympians 1981–1998)
↑
Lemez and Baker Sports Medicine - Open  (2015) 1:16 Page 6 of 14
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Mixedb Samaras et al. [61] (2002) 1505 Modest correlation coefficients indicated that weight is only
one risk factor that affected the longevities of baseball players
(n = 1278; r = −0.22, P < 0.025) [58], football players (n = 199;
r = −0.33, P < 0.005) [59], and Finnish elite athletes (r = −0.51,
non-significant) [5]
–
Mixedi Sarna et al. [5, 6] (1993, 1997) 2613 LE for endurance (5.7; M= 75.6, CI 73.6–77.5), team (4.0; M = 73.9,
CI 72.7–75.1), and in power (1.6; M= 71.5, CI 70.4–72.2) sport
athletes was greater than the referents (69.9); decreased CVD in
endurance (OR = 0.49, CI 0.26–0.93) and team (OR = 0.61,
CI 0.41–0.92) sport athletes (active 1920–1965)
↑
Mixed Zwiers et al. [31] (2012) 9889 High-intensity sport athletes had lower longevity compared to
low-intensity sport athletes (high risk of bodily collision,
HR = 1.11, CI 1.06–1.15, and high levels of physical contact,
HR = 1.16, CI 1.11–1.22 (Olympians 1896–1936; sex breakdown
unknown)
–
Studies with no subscript analyzed multiple countries, or other sports were used as controls. Full citations provided in reference list; all LE and MR data were
compared to age-matched controls from the GP and all studies were on male participants, unless stated otherwise; descriptions reflect only the key findings
AD Alzheimer’s disease, ALS amyotrophic lateral sclerosis, BMI body mass index, CI confidence interval, CVD cardiovascular disease, GP general population, HOF hall
of fame, HR hazard rate/ratio of death, LE life expectancy, M mean, MLB Major League Baseball, MR mortality rate, NBA National Basketball Association, NFL National
Football League; OR odds ratio for mortality, PL powerlifting, R² explained variation/total variation (coefficient of determination), RCS relative conditional survival,
RSR relative survival ratio, SD standard deviation, SMR standardized mortality ratio, SPMR standardized proportionate mortality ratio, SW sumo wrestling, T and F track
and field
aUSA
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cohort of the population (e.g., social media users; see
Table 2). Specifically, these three additional articles were
located through Google Scholar’s search engine using
the same keywords as used in the Web of Science data-
base search (e.g., athletes, death, etc.). We assessed the
quality of each of these records through the Newcastle-
Ottawa Quality Assessment Scale for cohort studies
[34]. See Fig. 1 for the PRISMA statement [33].
Measured Outcomes
This review was comprised of elite athlete mortality/
longevity studies from 13 different countries: USA,
France, Italy, Belgium, Norway, Sweden, Finland, New
Zealand, Netherlands, Germany, Japan, Poland, and the
UK. Measures of mortality included hazard rate/ratio of
death (HR), life expectancy (LE), mortality rate (MR),
odds ratio for mortality (OR), relative conditional sur-
vival (RCS), relative survival ratio (RSR), standardized
mortality ratio (SMR), and standardized proportionate
mortality ratio (SPMR). All LE and MR data were
compared to age-matched controls from the general
population and all studies were on male participants, un-
less stated otherwise in the tables.Results
Literature Search
From 1 January 1980 to 30 September 2014, we located
54 peer-reviewed studies [3–6, 8–15, 17–31, 35–61] and
three online articles [62–64] that examined mortality
and longevity in elite athletes (n = 57). This is an
addition of 43 peer-reviewed studies that were not in-
cluded in Teramoto and Bungum’s [16] review (11 peer-
reviewed studies overlap). Three peer-reviewed studies
from their review did not match our inclusion criteria
(<1980).
Summary of Life Expectancy in Elite Athletes from
Literature
This review included a total of 465,575 athletes: 450,295
from peer-reviewed literature (Table 1) and 15,280 from
online articles (Table 2). Of those 465,575 examined, only
5610 (1.2 %) were female athletes. Although it appears
that females have been grossly underrepresented in mor-
tality and longevity studies of elite athletes, the extremely
low proportion of 1.2 % is skewed by separate studies
examining the same cohort of players [e.g., 12 and 19,
n = 3439; 3–6, active Finnish athletes from 1920 to 1965),
single studies that contained very large sample sizes of
Table 2 Online elite athlete mortality articles (n = 3)
Sport/Country Authors N Key finding LE vs. GP
NFLa Baron and Rinsky [62] (NIOSH) (1994) 6848 NFL players had a 46 % decreased MR (SMR = 0.54); linemen
had a 52 % greater risk of death from heart disease than the
GP, and three times the risk compared to football players;
players had a decreased risk of death from violence (79 %) and
accidents (39 %); (players since 1959; death through 1991)
↑
NFLa Hargrove [63] (Scripps Howard News Service) (2006) 3850 The heaviest NFL players were more than twice as likely to die
before their 50th birthday than their teammates; players are
generally not dying sooner than average, but offensive and
defensive linemen had a 52 % greater risk of dying from heart
disease than the GP; out of the 130 players who died before
age 50, 1/69 players born since 1955 are dead, 22 % of which
died of heart diseases (77 % qualified as obese) and 19 % from
homicides or suicides; when compared to 2403 MLB players
who have died in the last century, NFL players are more than
twice as likely to die before age 50 (born since 1905)
–
Mixeda Barnwell [64] (Grantland) (2012) 4582 12.8 % of football players had died (n = 3088) compared to
15.9 % of baseball players (n = 1494) as of 2007 (active from
1959–1988)
–
AD Alzheimer’s disease, ALS amyotrophic lateral sclerosis, BMI body mass index, CI confidence interval, CVD cardiovascular disease, GP general population, HOF hall
of fame, HR hazard rate/ratio of death, LE life expectancy, M mean, MLB Major League Baseball, MR mortality rate, NBA National Basketball Association, NFL National
Football League; OR odds ratio for mortality, PL powerlifting, R² explained variation/total variation (coefficient of determination), RCS relative conditional survival,
RSR relative survival ratio, SD standard deviation, SMR standardized mortality ratio, SPMR standardized proportionate mortality ratio, SW sumo wrestling, T and F track
and field
aUSA
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the breakdown of sex in the sample went unreported (e.g.,
[31]). Nevertheless, only 6 peer-reviewed studies on elite
athlete mortality and longevity that included females in
their samples were identified [9, 20, 24, 31, 58, 60] and no
studies that investigated females exclusively.Fig. 1 Flow of information through the different phases of the systematic rev
identified through searching the references of records that were identified thFrom the 9-point Newcastle-Ottawa Quality Assessment
Scale [34], 1 study had a quality score of 6, 6 studies had a
quality score of 7, 32 studies had a quality score of 8, and
15 studies had a quality score of 9 (only peer-reviewed
articles were assessed). Therefore, the majority of the
studies included in this review were generally of highiew, as per the PRISMA statement [33]. *Additional records were
rough database searching and a general web search (i.e., Google Scholar)
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matched control groups from the general population, etc.).
Of the 54 peer-reviewed studies included, 4 were re-
sponses to the authors of different studies related to mor-
tality and longevity of elite athletes [29, 30, 42, 44]. Aside
from the studies or reviews that examined multiple sports,
professional baseball players (n = 16), football players
(4 peer-reviewed, 2 online), soccer players (n = 4), basketball
players (n = 3), and cyclists (n = 3) were identified through
our literature search as having the most reported data on
elite athletes’ mortality outcomes. In particular, MLB
players [15, 36, 38, 45–47], NFL players [12, 19, 49, 62], cy-
clists [13, 27, 28], NBA players [10, 48], and golfers [11, 21]
had the most robust evidence of greater longevity. These
LE benefits generally ranged from 4 to 8 years [e.g., 36 and
28, respectively].
The majority of studies included in this review exam-
ined sport organizations that were primarily located in
the USA and used age- and sex-matched controls that
were also American (MLB, NBA, and NFL). The general
finding of these studies was a greater longevity for elite
athletes relative to their American controls. Notably, the
majority of mixed-sport studies included in this review
also found support for greater longevity for athletes who
competed at elite levels of competition (e.g., Olympics).
Similarly, the “one-off” studies from international re-
searchers whose controls spanned 12 different countries
also reflect a general trend towards increased survival
rates for a diverse group of athletes relative to their
country-specific controls from the general population.
For example, elite cyclists, such as French, Italian, and
Belgian Tour de France participants, had greater lifespan
longevities when compared to the pooled general popu-
lation from their respective countries for the appropriate
age cohorts [13, 27, 28]. Further, Norwegian divers [8]
and skiers [22] and Italian track and field athletes [58]
had greater lifespan longevities relative to controls from
their respective countries as well. Alternatively, less con-
sistent results were found in soccer players, in which
both superior survival rates in Dutch players [23] and in-
ferior survival rates in German players [24] were reported,
alongside increases in amyotrophic lateral sclerosis (ALS)
prevalence in Italian players [55, 56]. In addition, elite
Finnish powerlifters [53] displayed lower lifespan longe-
vities compared to the Finnish general population.
Mechanisms of Mortality and Primary Outcomes
Considerable research attention has been given to identi-
fying which mechanisms may be precursors to early mor-
tality, including handedness, precocity, names and initials
of players/athletes, playing position and weight, education
and race, achievement, and energy system classifications.
First, the relationship between handedness and mortality
in elite athletes has received increased attention withinthe last two decades. Nevertheless, differences in longevity
related to handedness appear to be non-existent in MLB
[35, 42, 44] and NBA players [25]. While a relationship be-
tween longevity and handedness was identified in elite
cricketers [51], the inclusion of a larger sample size ap-
pears to have washed out previous significant findings
[52]. Second, the precocity-longevity hypothesis (see [65]),
which investigates the relationship between precocious-
ness (i.e., career debut) and early death, has been shown
to affect MLB players’ longevities [39]. Third, MLB players
with positive initials in their names (e.g., A.C.E.) were
found to live significantly longer than players with nega-
tive initials (e.g., D.E.D.) [40] while baseball, hockey, foot-
ball and basketball players with names beginning with D
had shorter lifespans than those with names beginning
with E to Z [17]. It is noteworthy that there has been some
criticism regarding the methodologies used in these stud-
ies, such as using selective data and the appropriateness of
the statistical tests performed [29, 30]. Further, while it has
been suggested that health is influenced by certain symbolic
aspects of the environment [66], such as a decreased preva-
lence of death before birthdays (e.g., [67]), the scientific ra-
tionale behind the initials of a name affecting lifespan
longevity is limited. In turn, the emergence of a hypothet-
ical name-longevity relationship in elite athletes emphasizes
the need for greater replication in this area of research.
An athlete’s playing position is arguably the most obvious
mechanism that influences mortality risk, largely due to
perceived anthropometric differences that are determinants
of health (e.g., weight). Longevity was found to be corre-
lated with position in MLB [47] and NBA players [48]. In
particular, weight and position significantly influenced mor-
tality risk in NFL players [19, 49, 50, 61–63, 68]. Further,
weight also influenced the lifespan longevities of baseball
players [61, 69] and played a role in the longevities of
Japanese sumo wrestlers, although its influence appeared
to be small [OR = 1.08, CI 1.01–1.15; 57]. With regard to
athlete race, this has been shown to be associated with lon-
gevity in NBA [10] and NFL players [19], as well as with
education and longevity in MLB players [45]. Sixth, high
achievement in sport emerged as a determinant of morta-
lity, specifically through winning percentage in Japanese
sumo wrestlers [57], handicap in Swedish golfers [11], and
Hall of Fame (HOF) induction in a diverse range of sports
[37, 59]. Although Abel and Kruger [37] reported differ-
ences in the life expectancies of MLB HOFs compared to
non-inductees, Smith [30] did not find a statistically signifi-
cant difference using corrected data from the same sample.
The last trend that developed from these studies, which
served as a classification method for Teramoto and
Bungum’s [16] review, was the relationship between the
type of sport and required energy systems for participation
(i.e., aerobic/endurance, mixed, and anaerobic/power)
and mortality. Similar to Teramoto and Bungum’s [16]
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endurance and mixed-sport athletes. The greatest LE ad-
vantages were found in European cyclists [13, 27, 28],
whereas the lowest LEs were found in Finnish power-
lifters [53]. Cross-sport analyses uniformly reported LE
advantages in endurance and mixed-sport athletes com-
pared to power sport athletes [3–6, 20, 31], who had some
evidence of increased premature mortality from suicide
suspected from prior anabolic steroid use [26, 53]. The in-
consistent mortality outcomes in power sport athletes
make it difficult to generalize across all sports. Neverthe-
less, there was considerable support in the existing litera-
ture for superior longevity outcomes for elite athletes
compared to the age- and sex-matched controls from the
general population.
Discussion
The objective of our review was to advance knowledge
on elite athlete mortality and longevity to ultimately de-
termine whether elite-level participation in high-
performance sport produces a lifespan longevity advan-
tage. As a whole, the empirical evidence suggests that
several mechanisms within and between sports have
powerful effects on the overall lifespan longevities of
players. Our first research question considered whether
elite athletes had superior longevity outcomes relative to
the general population. An overwhelming majority of
studies included in this review reported favorable life-
span longevities for athletes compared to their age- and
sex-matched controls from the general population. In
fact, only two studies reported lower lifespan longevities
in athletes relative to the controls: 812 male and female
soccer players who participated in international matches
for Germany between 1908 and 2006 (RSR ≤ 1) [24], and
62 male Finnish powerlifters who placed first–fifth in
their respective weight category in the Finnish champi-
onships between 1977 and 1982 (SMR = 4.6) [53]. Our
second research question explored the mechanisms and
risk factors associated with longevity and whether there
were precursors to early mortality. Although our overall
understanding of modifiable and non-modifiable factors
that contribute to mortality risk in elite athletes remains
limited, in part due to methodological and data source
inconsistencies [29, 30], some trends emerged from our
investigation. In particular, our review supports previous
conclusions that aerobic and mixed-sport athletes have
superior longevity outcomes relative to more anaerobic
sport athletes. In addition, playing position and weight,
as well as education and race, appeared to be consistent
indicators of mortality risk, whereas other mechanisms
such as handedness, precocity, and names and initials
appeared to be less consistent and/or examined.
In their review of the relationship between body size
and lifespan longevity, Samaras et al. [61] drew attentionto several confounders that may positively influence lon-
gevity outcomes, such as higher socioeconomic status,
smaller body size, and positive environmental and health
benefits. As highlighted in this review, weight is an
important predictor of mortality risk. Likewise, signifi-
cant empirical evidence suggests that obesity is one of
the major risk factors for premature death (e.g., [70]).
While it is premature to undervalue the relationship be-
tween weight and mortality in athletes, particularly post-
retirement, research has also highlighted the importance
of accounting for body composition. For example, it has
been suggested that a measure of BMI is likely to over-
estimate adiposity in muscular athletes (e.g., [71]), par-
ticularly in NFL players [19]. In addition, Koning and
Amelink [23] highlighted that self-selecting to partici-
pate in an occupation where health is important may
predispose athletes to favorable survival outcomes rela-
tive to population comparisons. Factors such as these, in
addition to a bevy of other confounders such as access
to high-quality medical care [23], are what make LE a
difficult outcome to accurately predict.
As a variety of confounders may impact longevity, the
reasons for the differences in lifespans between elite
athletes and the general population are likely to be
multifactorial. Teramoto and Bungum [16] provided
possible explanations of increased survival in the elite
athlete cohort; namely, participation in higher volumes
of exercise training leading to higher physical fitness
levels, the likelihood that elite athletes are comprised of
the healthiest and fittest individuals, and the main-
tenance of active and healthy lifestyles later in life. The
extents to which these confounders contribute to mor-
tality risk are still largely unknown however, as survival
statistics may undermine the interplay of complex so-
cioeconomic factors [72]. For example, medical care
accessibility made available by higher income may
improve the LE of athletes when compared to other
groups. Further, plenty of corroborating evidence sug-
gests health-care services alone do not result in im-
proved health outcomes, but a variety of social factors
such as education and employment produce these
widespread biases in health (e.g., [73]). As a result, the
historical investigations of elite athletes and longevity
outcomes need to be cautiously interpreted and dis-
cussed in the contexts of a variety of possible influential
factors of mortality.
Abel and Kruger [17] discussed two advantages to
studying elite athletes with regards to longevity. First,
they represent a relatively homogenous occupational
population, similar to Teramoto and Bungum’s [16] clas-
sification of a distinct physically fit and healthy group,
and, perhaps more importantly, many sports contain
detailed statistical and historical databases that track a
variety of variables that can influence longevity (e.g.,
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induction into the HOF, etc.). These advantages help
contribute to the growing body of research on elite ath-
lete mortality trends, which in turn can advance research
by forming evidence-based models of athlete longevity
through investigations into a variety of variables. In con-
trast, a caveat to this tendency of measuring the effects
of sport-specific variables on mortality is that the
amount of data available varies from sport to sport and
may be somewhat arbitrary. For example, handedness is
unlikely to be measured in soccer players, and the in-
fluence of position in non-contact sports may be more
relevant in life quality research rather than life longevity.
In addition, each sport will have a different inaugural
season, which limits the amount of deceased players in
the relatively newer sports (e.g., mixed martial arts).
Therefore, each sport will have unique statistical vari-
ables that may make it more difficult for researchers to
draw cross-sport comparisons.
Limitations
The main finding of this systematic review indicates
favorable lifespan longevity advantages for elite athletes
relative to age- and sex-matched controls from the gen-
eral population; however, limitations in reviewing litera-
ture on mortality and longevity in elite athletes exist.
We will first examine the possible biases in epidemio-
logical research in historical samples of athletes.
Databases
The use of accurate and up-to-date databases is ex-
tremely important when analyzing a sample longitudi-
nally; however, some statistical databases for past players
have been found to be incomplete. For example, Smith
[30] discovered a substantial portion of missing death
date data (e.g., unknown death dates) in former MLB
players in the Sean Lahman Baseball Archive [74]. Un-
fortunately, Smith’s [30] critique of Abel and Kruger’s
[37] conclusion (cases without death date data were
treated as living players) that HOF non-inductees had a
5-year lifespan longevity advantage was not the only
study on MLB player longevity that used the same data-
base (e.g., [17, 35, 36, 38–40, 45]). Although it may be
premature to conclude that other databases have similar
fallibility (e.g., missing death date data), we must be cau-
tious of the possible incongruency between reported and
unreported/unknown death date data in other studies
that bias lifespan longevity results.
Holistic Health
As a variety of socioeconomic, demographic, and epide-
miologic factors dynamically interact to shape popula-
tion change [72], so do factors that influence holistic
health. Arguably, the most objective measurement ofelite athlete health is rate of mortality. Using mortality
statistics of elite athletes who played in the earlier de-
cades to make inferences regarding holistic health in
present-day athletes may be deceptive. The information
age has made information on elite athletes easy to ac-
cess, whereas information on elite athletes from the
earlier eras often fails to depict the mental and social
wellbeing characteristics that encompass holistic health.
Sorenson et al.’s [75] investigation of lifespan exercise
among elite intercollegiate athletes is one of few studies
that have presented empirical evidence of lifetime health
and wellbeing in modern competitive athletes relative to
age- and sex-matched controls. They found that current
student athletes reported higher volumes of weekly exer-
cise, perceived exercise importance, and likelihood of
compliance with American College of Sports Medicine
(ACSM) exercise guidelines relative to non-athletes [75].
Interestingly, Sorenson et al. [75] found no significant
differences between alumni student athletes and non-
athletes, suggesting that former athletes failed to main-
tain higher exercise levels later in life. Further, in their
follow-up study on the same sample, Sorenson et al. [76]
found that relatively older former student athletes (age
43+ years) had a greater risk for joint health concerns
later in life compared to a non-athlete control group.
These findings seem counterintuitive since physical ac-
tivity is often associated with a substantial reduction of
chronic disease risk and being important to overall
health and wellbeing (e.g., [77]).
To broaden our knowledge on holistic health out-
comes and behavior in former athletes, it is important to
consider the totality of data that have been collected and
analyzed to date, particularly as research pertaining to
the “whole person” (e.g., physical and psychosocial mea-
sures) in modern competitive athletes gains momentum.
It is equally important to make the distinction between
“quality of life” and “longevity,” as physical health likely
moderates psychosocial health. For example, evidence
suggests that physical activity plays an important role in
managing mental health diseases, such as anxiety and
depression (e.g., [78]). Thus, factors such as being phy-
sically capable to participate in physical activity are im-
portant to consider when determining an individual’s
quality of life. As such, our current understanding of
elite athletes’ quality of life during and after sport is
limited relative to their lifespan longevity trends.
Statistical Measures
Another criticism of the athlete-mortality literature is on
methodological grounds; more specifically, cross-study
discrepancies in the statistical tests and/or measures used.
Although the relative paucity of lifespan longevity studies
of elite athletes may serve as a temporary explanation for
why different measures and control variables are used to
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statistical bias risk. Risk of bias can affect the cumulative
evidence of a review of literature [33], such as selective
reporting within studies, whereby researchers may under-
report variables that were found to have less statistical
impact on longevity outcomes in the course of reporting
results that support the direction of their findings. As a re-
sult, the extent of our knowledge about the influence of
certain variables on longevity may be restricted. Future
work in this area of research would benefit from replica-
tion of control variables when analyzing the same or simi-
lar athletic populations to better establish important
predictors of longevity. Further, meta-analyses on the
longevity of elite athletes, such as the review completed
by Garatachea and colleagues [7], can provide more
evidence-based data on the benefits of participating in
physical activity. Moreover, it is notable that the sports ex-
amined have examined periods of different length. Ideally,
comparisons would be best when comparing timespans of
similar length; however, the timespans investigated have
ranged from players being born from as early as 1840 [52]
to being active as recently as 2012 [27]. These differences
could affect the proportion of those living or dead in a
sample, which may affect measures such as SMR. The im-
plication of these biases on the cumulative evidence of this
review is unclear, and as a result, it is important to con-
sider how publication bias can under- and overestimate
certain predictors of longevity.
Longitudinal Lifestyle Factors
Given that empirical evidence is necessary for coherent ex-
planations of longevity outcomes of elite athletes, do
mechanisms that influence mortality become ineffective
and/or less powerful if maintenance of physical activity
ceases? Although there has been some evidence that
former intercollegiate student athletes fail to maintain
higher exercise levels later in life [75], our understanding
of the impact of different longitudinal lifestyle factors influ-
encing lifespan longevity remains incomplete. For example,
former male Finnish world class athletes were found to be
more active than their non-competitive controls [79], and
participation in physical activity at a young age predicted
later life involvement, which reduced the prevalence of cor-
onary heart disease [80]. In addition, former athletes have
been found to partake in fewer negative health habits, such
as smoking and drinking alcohol [79].
Another issue that is emerging from more recent re-
search relates to the possible detrimental effects of high
levels of training. In particular, O’Keefe (e.g., [81, 82]) has
advocated that “excessive” aerobic training can result in
cardiovascular damage (e.g., atrial fibrillation, coronary ar-
tery disease, and malignant ventricular arrhythmias).
These effects may have particular relevance for studies of
mortality in previously elite athletes. It is important forfuture research to determine which factors are more ro-
bust predictors of longevity and if they continue to be
relevant in later life. In turn, these findings will have impli-
cations on the generalizability of factors found to predict
mortality and longevity in elite athletes that were mea-
sured at one point in time (i.e., active athletic career).
Future Directions
The relationship between sport and health has evolved
considerably over the past 100 years. The context in which
the historical data are transferable is important to consider,
particularly when discussing the social determinants of
health [73]. Despite its limitations, historical analyses of
sport and health shape our present understanding of its re-
lationship and influence.
Reliable Databases, Repetition, Causes of Mortality, and
Follow-up Studies
Continued contributions to the growing body of re-
search on longevity outcomes of elite athletes should
utilize appropriate statistical testing with reliable and
complete databases. Although there are a variety ways to
statistically measure and report mortality, research must be
substantiated through repetition. An important first step is
locating or comprising a reliable and comprehensive data-
base that embodies all accessible and applicable data. To
this end, future research of athlete lifespan outcomes can
arguably have the greatest impact by determining the
causes of mortality. Current empirical evidence on the
rates of mortality in athletes is far superior to our know-
ledge on the causes of mortality. Epidemiological studies
with long-term follow-ups are also rare [55]. For example,
available evidence suggests a possible connection between
dietary supplements and/or drug use and the high preva-
lence of amyotrophic lateral sclerosis (ALS) in former soc-
cer players [55, 56]. This potential association emphasizes
negative long-term neurological outcomes of performance
demands that are not reflected in MR occurrence.
Cross-sport Comparisons and Generalizability
Several sports were noticeably absent from the elite athlete
mortality literature (e.g., ice hockey, field hockey, handball,
snowboarding, table tennis, volleyball, and motorsports). In
addition, sex-related differences in lifespan longevity re-
main largely unknown due to the paucity of studies on elite
female athletes. This raises an important concern about
the cross-sport generalizability disseminated in this review.
Perhaps more importantly, the applicability of these results
to the general population (i.e., non-elite-athletes) can likely
be best explained by mechanisms of mortality that have
not been extensively examined to date in the athlete co-
hort. Some examples include smoking and diet/nutrition
(as stated by Teramoto and Bungum) [16], lifespan health
(psychosocial and physical, such as the influence of
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(hereditary, such as superior genotypes for physical fitness)
(e.g., [83]) and nurture (environmental influences). Pre-
sumably, elite athletes possess advantageous genetic traits.
Research on the heritability of physical fitness (e.g., [84])
suggests that we cannot discount the influence of advanta-
geous genetic inheritance coupled with high levels of par-
ticipation and competition in sport.
Conclusions
Mechanisms such as type of sport, playing position,
weight, education, and race can inform our understand-
ing of lifespan longevity, which places increased respon-
sibility on future research to demystify and contextualize
mortality risk in both eminent and non-eminent popula-
tions. In conclusion, while additional research studies
are needed to address quality of life and wellness out-
comes, this review highlights mortality trends among
elite athletes and concludes that participation in elite
sport is generally favorable to lifespan longevity.
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